
COVID-19 in hemodialysis patients: Experience from a Western Indian center
Author(s) -
DivyeshP Engineer,
Subho Banerjee,
HimanshuV Patel,
Vaibhav Gupta,
Hardik Patel,
Aakash Gupta,
Parth Shah,
VivekB Kute
Publication year - 2022
Publication title -
indian journal of nephrology/indian journal of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.317
H-Index - 24
eISSN - 1998-3662
pISSN - 0971-4065
DOI - 10.4103/ijn.ijn_575_20
Subject(s) - medicine , ards , hemodialysis , hydroxychloroquine , kidney disease , comorbidity , population , renal replacement therapy , dialysis , acute kidney injury , diabetes mellitus , pediatrics , intensive care medicine , disease , covid-19 , lung , infectious disease (medical specialty) , environmental health , endocrinology
Chronic kidney disease patients on hemodialysis (CKD-5D) are among the worst hit by the coronavirus disease 2019 (COVID-19) pandemic. Need to travel for dialysis, comorbidities, and immunosuppressive state put them at risk of severe disease and poor outcomes. We report our experience of COVID-19 in a cohort of CKD-5D from a public sector tertiary-care center from western India.